1. Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses
   Ilyas Sahin et al, 2019, Cancer Biology & Therapy CrossRef
2. Construction and Validation of a Necroptosis-Related Gene Signature for Predicting Prognosis and Tumor Microenvironment of Pancreatic Cancer
   Cheng Ding et al, 2022, Disease Markers CrossRef
3. Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma
   Meng Zhang et al, 2022, Frontiers in Pharmacology CrossRef
4. Integrating Machine Learning and Mendelian Randomization Determined a Functional Neurotrophin-Related Gene Signature in Patients with Lower-Grade Glioma
   Cong Zhang et al, 2024, Molecular Biotechnology CrossRef
5. Links between the unfolded protein response and the DNA damage response in hypoxia: a systematic review
   Hannah Bolland et al, 2021, Biochemical Society Transactions CrossRef
6. Crosstalk between Wnt/β-catenin signaling pathway and DNA damage response in cancer: a new direction for overcoming therapy resistance
   Xixia Zhang et al, 2023, Frontiers in Pharmacology CrossRef
7. Glycogen Synthase Kinase-3 Beta Expression Correlates With Worse Overall Survival in Non-Small Cell Lung Cancer—A Clinicopathological Series
   Marclesson Alves et al, 2021, Frontiers in Oncology CrossRef
8. The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies
   Semer Maksoud, 2022, Molecular Neurobiology CrossRef
9. GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models
   Anke Brüning-Richardson et al, 2021, Cancers CrossRef